<code id='57AF8F5E6F'></code><style id='57AF8F5E6F'></style>
    • <acronym id='57AF8F5E6F'></acronym>
      <center id='57AF8F5E6F'><center id='57AF8F5E6F'><tfoot id='57AF8F5E6F'></tfoot></center><abbr id='57AF8F5E6F'><dir id='57AF8F5E6F'><tfoot id='57AF8F5E6F'></tfoot><noframes id='57AF8F5E6F'>

    • <optgroup id='57AF8F5E6F'><strike id='57AF8F5E6F'><sup id='57AF8F5E6F'></sup></strike><code id='57AF8F5E6F'></code></optgroup>
        1. <b id='57AF8F5E6F'><label id='57AF8F5E6F'><select id='57AF8F5E6F'><dt id='57AF8F5E6F'><span id='57AF8F5E6F'></span></dt></select></label></b><u id='57AF8F5E6F'></u>
          <i id='57AF8F5E6F'><strike id='57AF8F5E6F'><tt id='57AF8F5E6F'><pre id='57AF8F5E6F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:9676
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Welsh Carson private equity firm escapes from FTC antitrust case
          Welsh Carson private equity firm escapes from FTC antitrust case

          AjudgeruledthatWelshCarsonwon'thavetofaceantitrustallegationsaboutitsanesthesiologypractice.AdobeWel

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Brain technologies pose threats that are all too real, experts warn

          Inthe2011film"Limitless,"mysterypillsletBradleyCooper'sstrugglingwriteraccess100percentofhisbrain,ma